Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | XDH | P47989 | 2/20 | 0.61 |
| ▸ | GP6 | Q9HCN6 | 2/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | HPGDS | O60760 | 1/20 | 0.54 |
| ▸ | ADH5 | P11766 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1249156 | 0.89 | KMT2A (0.61) | KMT2ALMNAALDH1A1TP53XDH | |
| SCHEMBL1250582 | 0.85 | XDH (0.72) | KMT2ALMNAXDH | |
| SCHEMBL1248713 | 0.84 | SLC22A12 (0.68) | XDHGP6 | |
| SCHEMBL12458012 | 0.82 | GP6 (0.49) | KMT2ALMNAGP6HPGDS | |
| SCHEMBL1249112 | 0.81 | KMT2A (0.62) | KMT2ALMNAALDH1A1GP6L3MBTL1 | |
| SCHEMBL1248177 | 0.80 | GP6 (0.56) | KMT2ALMNAALDH1A1TP53GP6 | |
| SCHEMBL31530110 | 0.80 | LMNA (0.62) | KMT2ALMNAALDH1A1TP53XDH | |
| SCHEMBL7901106 | 0.79 | GRIK1 (0.55) | GP6 | |
| SCHEMBL1249214 | 0.79 | RHEB (0.51) | KMT2ALMNAGP6 | |
| SCHEMBL4667928 | 0.78 | LMNA (0.51) | KMT2ALMNAXDHCYP2C19L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101774-B2 | Ester derivatives and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8101774-B2 | Ester derivatives and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8101774-B2 | Ester derivatives and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2012-01-24 | — | — | US | disclosed |
| CN-101056628-B | Ester derivatives and medicinal use thereof | JAPAN TOBACCO INC | 2011-05-25 | — | — | CN | disclosed |
| US-7879893-B2 | Zinc binding ligand; sustained release of insulin | NOVO NORDISK A/S (DK) | 2011-02-01 | — | — | US | disclosed |
| CN-101056628-A | Ester derivatives and medicinal use thereof | JAPAN TOBACCO INC (JP) | 2007-10-17 | — | — | CN | disclosed |
| EP-1803452-A1 | ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF | Japan Tobacco, Inc. (JP) | 2007-07-04 | — | — | EP | disclosed |
| US-20060089392-A1 | Ester derivatives and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2006-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060089392-A1 | Ester derivatives and medicinal use thereof | MTTP, CETP, LIPA | KMT2A 3181/4885LMNA 2858/4885ALDH1A1 421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.